Dan Shores Featured in Three-Part Series for Advancing RNA on Patent Landscape and IP Considerations in RNA

Print PDF Icon

Partner Dan Shores is featured in a three-part series on Advancing RNA covering topics such as the mRNA patent landscape and IP considerations for early-stage companies. Through a series of conversations with Advancing RNA's Editorial & Community Director Anna Rose Welch, Dan shares his insight and expertise. You can find links to parts 1 and 2 below.

Advancing RNA is a Life Science Connect community focused on the rapidly evolving field of RNA-based therapeutics. It aims to provide valuable insights, discussions, and resources for professionals developing RNA-based drugs. Primary members of the community consist of individuals from biopharma organizations engaged in pre-BLA development, often in the pre-IND discovery stage. The community addresses various challenges in RNA therapy development, including analytical, quality, manufacturing, and regulatory issues. Additionally, Advancing RNA is positioned within the broader Life Science Connect network, allowing members to access additional resources as needed for their RNA therapy development journey. Learn more at advancingrna.com. 

Jump to Page

Necessary Cookies

Necessary cookies enable core functionality such as security, network management, and accessibility. You may disable these by changing your browser settings, but this may affect how the website functions.

Analytical Cookies

Analytical cookies help us improve our website by collecting and reporting information on its usage. We access and process information from these cookies at an aggregate level.